ID   COHA1_HUMAN             Reviewed;        1497 AA.
AC   Q9UMD9; Q02802; Q5JV36; Q99018; Q9NQK9; Q9UC14;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 3.
DT   07-APR-2021, entry version 182.
DE   RecName: Full=Collagen alpha-1(XVII) chain;
DE   AltName: Full=180 kDa bullous pemphigoid antigen 2;
DE   AltName: Full=Bullous pemphigoid antigen 2;
DE   Contains:
DE     RecName: Full=120 kDa linear IgA disease antigen;
DE     AltName: Full=120 kDa linear IgA dermatosis antigen;
DE     AltName: Full=Linear IgA disease antigen 1;
DE              Short=LAD-1;
DE   Contains:
DE     RecName: Full=97 kDa linear IgA disease antigen;
DE     AltName: Full=97 kDa linear IgA bullous dermatosis antigen;
DE              Short=97 kDa LAD antigen;
DE              Short=97-LAD;
DE     AltName: Full=Linear IgA bullous disease antigen of 97 kDa;
DE              Short=LABD97;
GN   Name=COL17A1; Synonyms=BP180, BPAG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND VARIANT
RP   SER-428.
RC   TISSUE=Foreskin;
RX   PubMed=1324962; DOI=10.1111/1523-1747.ep12616580;
RA   Giudice G.J., Emery D.J., Diaz L.A.;
RT   "Cloning and primary structural analysis of the bullous pemphigoid
RT   autoantigen, BP180.";
RL   J. Invest. Dermatol. 99:243-250(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANTS ILE-231;
RP   THR-238; SER-428; VAL-703 AND GLY-1370.
RX   PubMed=9012408;
RA   Gatalica B., Pulkkinen L., Li K., Kuokkanen K., Ryynaenen M., McGrath J.A.,
RA   Uitto J.;
RT   "Cloning of the human type XVII collagen gene (COL17A1), and detection of
RT   novel mutations in generalized atrophic benign epidermolysis bullosa.";
RL   Am. J. Hum. Genet. 60:352-365(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-390, AND VARIANT MET-210.
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 508-856, AND TISSUE SPECIFICITY.
RX   PubMed=1748679;
RA   Li K.H., Sawamura D., Giudice G.J., Diaz L.A., Mattei M.-G., Chu M.-L.,
RA   Uitto J.;
RT   "Genomic organization of collagenous domains and chromosomal assignment of
RT   human 180-kDa bullous pemphigoid antigen-2, a novel collagen of stratified
RT   squamous epithelium.";
RL   J. Biol. Chem. 266:24064-24069(1991).
RN   [6]
RP   PROTEIN SEQUENCE OF 524-535.
RX   PubMed=14675210; DOI=10.1046/j.1523-1747.2003.12607.x;
RA   Hirako Y., Nishizawa Y., Sitaru C., Opitz A., Marcus K., Meyer H.E.,
RA   Butt E., Owaribe K., Zillikens D.;
RT   "The 97-kDa (LABD97) and 120-kDa (LAD-1) fragments of bullous pemphigoid
RT   antigen 180/type XVII collagen have different N-termini.";
RL   J. Invest. Dermatol. 121:1554-1556(2003).
RN   [7]
RP   PROTEIN SEQUENCE OF 531-546; 554-565; 585-605; 647-666; 680-688; 689-703;
RP   755-765; 842-860; 880-891; 1016-1028; 1062-1069; 1102-1108; 1134-1142;
RP   1227-1247 AND 1248-1260.
RX   PubMed=9506436; DOI=10.1046/j.1523-1747.1998.00129.x;
RA   Zone J.J., Taylor T.B., Meyer L.J., Petersen M.J.;
RT   "The 97 kDa linear IgA bullous disease antigen is identical to a portion of
RT   the extracellular domain of the 180 kDa bullous pemphigoid antigen,
RT   BPAg2.";
RL   J. Invest. Dermatol. 110:207-210(1998).
RN   [8]
RP   SUBCELLULAR LOCATION, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=8618013; DOI=10.1111/1523-1747.ep12345782;
RA   Marinkovich M.P., Taylor T.B., Keene D.R., Burgeson R.E., Zone J.J.;
RT   "LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa
RT   anchoring filament protein synthesized by epidermal cells.";
RL   J. Invest. Dermatol. 106:734-738(1996).
RN   [9]
RP   ERRATUM OF PUBMED:8618013.
RA   Marinkovich M.P., Taylor T.B., Keene D.R., Burgeson R.E., Zone J.J.;
RL   J. Invest. Dermatol. 106:1343-1343(1996).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=8618014; DOI=10.1111/1523-1747.ep12345793;
RA   Ishiko A., Shimizu H., Masunaga T., Hashimoto T., Dmochowski M.,
RA   Wojnarowska F., Bhogal B.S., Black M.M., Nishikawa T.;
RT   "97-kDa linear IgA bullous dermatosis (LAD) antigen localizes to the lamina
RT   lucida of the epidermal basement membrane.";
RL   J. Invest. Dermatol. 106:739-743(1996).
RN   [11]
RP   SUBCELLULAR LOCATION.
RA   Limardo M., Arffman A., Aho S., Utto J.;
RT   "Evidence that the 180-kD bullous pemphigoid antigen is a transmembrane
RT   collagen, type XVII, in a triple-helical conformation and in type II
RT   transmembrane topography.";
RL   J. Invest. Dermatol. 106:860-860(1996).
RN   [12]
RP   SUBUNIT, PROTEOLYTIC PROCESSING, GLYCOSYLATION AT ASN-1421, AND DOMAINS.
RX   PubMed=9748270; DOI=10.1074/jbc.273.40.25937;
RA   Schaecke H., Schumann H., Hammami-Hauasli N., Raghunath M.,
RA   Bruckner-Tuderman L.;
RT   "Two forms of collagen XVII in keratinocytes. A full-length transmembrane
RT   protein and a soluble ectodomain.";
RL   J. Biol. Chem. 273:25937-25943(1998).
RN   [13]
RP   INTERACTION WITH DSP.
RX   PubMed=10637308; DOI=10.1091/mbc.11.1.277;
RA   Hopkinson S.B., Jones J.C.;
RT   "The N terminus of the transmembrane protein BP180 interacts with the N-
RT   terminal domain of BP230, thereby mediating keratin cytoskeleton anchorage
RT   to the cell surface at the site of the hemidesmosome.";
RL   Mol. Biol. Cell 11:277-286(2000).
RN   [14]
RP   SHEDDING.
RX   PubMed=12356719; DOI=10.1093/emboj/cdf532;
RA   Franzke C.-W., Tasanen K., Schaecke H., Zhou Z., Tryggvason K., Mauch C.,
RA   Zigrino P., Sunnarborg S., Lee D.C., Fahrenholz F., Bruckner-Tuderman L.;
RT   "Transmembrane collagen XVII, an epithelial adhesion protein, is shed from
RT   the cell surface by ADAMs.";
RL   EMBO J. 21:5026-5035(2002).
RN   [15]
RP   FUNCTION, INTERACTION WITH DSP; DST; ITGB4 AND PLEC, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12482924; DOI=10.1242/jcs.00241;
RA   Koster J., Geerts D., Favre B., Borradori L., Sonnenberg A.;
RT   "Analysis of the interactions between BP180, BP230, plectin and the
RT   integrin alpha6beta4 important for hemidesmosome assembly.";
RL   J. Cell Sci. 116:387-399(2003).
RN   [16]
RP   PHOSPHORYLATION AT SER-544.
RX   PubMed=17545155; DOI=10.1074/jbc.m701937200;
RA   Zimina E.P., Fritsch A., Schermer B., Bakulina A.Y., Bashkurov M.,
RA   Benzing T., Bruckner-Tuderman L.;
RT   "Extracellular phosphorylation of collagen XVII by ecto-casein kinase 2
RT   inhibits ectodomain shedding.";
RL   J. Biol. Chem. 282:22737-22746(2007).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   TISSUE SPECIFICITY, INVOLVEMENT IN ERED, AND VARIANT ERED ILE-939.
RX   PubMed=25676728; DOI=10.1002/humu.22764;
RA   Jonsson F., Bystroem B., Davidson A.E., Backman L.J., Kellgren T.G.,
RA   Tuft S.J., Koskela T., Ryden P., Sandgren O., Danielson P.,
RA   Hardcastle A.J., Golovleva I.;
RT   "Mutations in collagen, type XVII, alpha 1 (COL17A1) cause epithelial
RT   recurrent erosion dystrophy (ERED).";
RL   Hum. Mutat. 36:463-473(2015).
RN   [19]
RP   VARIANT GABEB VAL-627.
RX   PubMed=8669466;
RA   McGrath J.A., Gatalica B., Li K., Dunnill M.G.S., McMillan J.R.,
RA   Christiano A.M., Eady R.A.J., Uitto J.;
RT   "Compound heterozygosity for a dominant glycine substitution and a
RT   recessive internal duplication mutation in the type XVII collagen gene
RT   results in junctional epidermolysis bullosa and abnormal dentition.";
RL   Am. J. Pathol. 148:1787-1796(1996).
RN   [20]
RP   VARIANT GABEB GLN-1303.
RX   PubMed=9199555; DOI=10.1086/515463;
RA   Schumann H., Hammami-Hauasli N., Pulkkinen L., Mauviel A., Kuester W.,
RA   Luethi U., Owaribe K., Uitto J., Bruckner-Tuderman L.;
RT   "Three novel homozygous point mutations and a new polymorphism in the
RT   COL17A1 gene: relation to biological and clinical phenotypes of junctional
RT   epidermolysis bullosa.";
RL   Am. J. Hum. Genet. 60:1344-1353(1997).
RN   [21]
RP   VARIANT GABEB VAL-627.
RX   PubMed=10652291; DOI=10.1074/jbc.275.5.3093;
RA   Tasanen K., Eble J.A., Aumailley M., Schumann H., Baetge J., Tu H.,
RA   Bruckner P., Bruckner-Tuderman L.;
RT   "Collagen XVII is destabilized by a glycine substitution mutation in the
RT   cell adhesion domain Col15.";
RL   J. Biol. Chem. 275:3093-3099(2000).
RN   [22]
RP   VARIANT GABEB ASP-633.
RX   PubMed=10951237; DOI=10.1046/j.1523-1747.2000.00049.x;
RA   Tasanen K., Floeth M., Schumann H., Bruckner-Tuderman L.;
RT   "Hemizygosity for a glycine substitution in collagen XVII: unfolding and
RT   degradation of the ectodomain.";
RL   J. Invest. Dermatol. 115:207-212(2000).
RN   [23]
RP   VARIANT GABEB CYS-265, AND VARIANT ILE-231.
RX   PubMed=11912005; DOI=10.1016/s0923-1811(01)00163-3;
RA   Wu Y., Li G., Zhu X.;
RT   "A novel homozygous point mutation in the COL17A1 gene in a Chinese family
RT   with generalized atrophic benign epidermolysis bullosa.";
RL   J. Dermatol. Sci. 28:181-186(2002).
CC   -!- FUNCTION: May play a role in the integrity of hemidesmosome and the
CC       attachment of basal keratinocytes to the underlying basement membrane.
CC   -!- FUNCTION: The 120 kDa linear IgA disease antigen is an anchoring
CC       filament component involved in dermal-epidermal cohesion. Is the target
CC       of linear IgA bullous dermatosis autoantibodies.
CC   -!- SUBUNIT: Homotrimers of alpha 1(XVII)chains. Interacts (via cytoplasmic
CC       region) with ITGB4 (via cytoplasmic region). Interacts (via cytoplasmic
CC       region) with DST isoform 3 (via N-terminus). Interacts (via N-terminus)
CC       with PLEC. Interacts (via cytoplasmic region) with DSP.
CC       {ECO:0000269|PubMed:10637308, ECO:0000269|PubMed:12482924,
CC       ECO:0000269|PubMed:9748270}.
CC   -!- INTERACTION:
CC       Q9UMD9; Q9H0L4: CSTF2T; NbExp=3; IntAct=EBI-2528742, EBI-747012;
CC       Q9UMD9; O60568: PLOD3; NbExp=3; IntAct=EBI-2528742, EBI-741582;
CC       Q9UMD9; Q96T60: PNKP; NbExp=3; IntAct=EBI-2528742, EBI-1045072;
CC       Q9UMD9; Q9Y3C6: PPIL1; NbExp=3; IntAct=EBI-2528742, EBI-2557649;
CC       Q9UMD9; Q9UHD9: UBQLN2; NbExp=3; IntAct=EBI-2528742, EBI-947187;
CC       Q9UMD9; Q9P202: WHRN; NbExp=3; IntAct=EBI-2528742, EBI-310886;
CC   -!- SUBCELLULAR LOCATION: Cell junction, hemidesmosome. Membrane; Single-
CC       pass type II membrane protein. Note=Localized along the plasma membrane
CC       of the hemidesmosome.
CC   -!- SUBCELLULAR LOCATION: [120 kDa linear IgA disease antigen]: Secreted,
CC       extracellular space, extracellular matrix, basement membrane.
CC       Note=Exclusively localized to anchoring filaments. Localized to the
CC       epidermal side of split skin.
CC   -!- SUBCELLULAR LOCATION: [97 kDa linear IgA disease antigen]: Secreted,
CC       extracellular space, extracellular matrix, basement membrane.
CC       Note=Localized in the lamina lucida beneath the hemidesmosomes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UMD9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UMD9-2; Sequence=VSP_024940, VSP_024941;
CC   -!- TISSUE SPECIFICITY: Detected in skin (PubMed:8618013). In the cornea,
CC       it is detected in the epithelial basement membrane, the epithelial
CC       cells, and at a lower level in stromal cells (at protein level)
CC       (PubMed:25676728). Stratified squamous epithelia. Found in
CC       hemidesmosomes. Expressed in cornea, oral mucosa, esophagus, intestine,
CC       kidney collecting ducts, ureter, bladder, urethra and thymus but is
CC       absent in lung, blood vessels, skeletal muscle and nerves.
CC       {ECO:0000269|PubMed:1748679, ECO:0000269|PubMed:25676728,
CC       ECO:0000269|PubMed:8618013}.
CC   -!- PTM: The intracellular/endo domain is disulfide-linked.
CC   -!- PTM: Prolines at the third position of the tripeptide repeating unit
CC       (G-X-Y) are hydroxylated in some or all of the chains.
CC   -!- PTM: The ectodomain is shedded from the surface of keratinocytes
CC       resulting in a 120-kDa soluble form, also named as 120 kDa linear IgA
CC       disease antigen. The shedding is mediated by membrane-bound
CC       metalloproteases. This cleavage is inhibited by phosphorylation at Ser-
CC       544. {ECO:0000269|PubMed:9748270}.
CC   -!- DISEASE: Generalized atrophic benign epidermolysis bullosa (GABEB)
CC       [MIM:226650]: A non-lethal, adult form of junctional epidermolysis
CC       bullosa characterized by life-long blistering of the skin, associated
CC       with hair and tooth abnormalities. {ECO:0000269|PubMed:10652291,
CC       ECO:0000269|PubMed:10951237, ECO:0000269|PubMed:11912005,
CC       ECO:0000269|PubMed:8669466, ECO:0000269|PubMed:9199555}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Epithelial recurrent erosion dystrophy (ERED) [MIM:122400]: A
CC       corneal dystrophy characterized by recurrent episodes of epithelial
CC       erosions from childhood, with occasional impairment of vision. Most
CC       patients have attacks of redness, photophobia, epiphora, and ocular
CC       pain. Exposure to sunlight or draught, dust and smoke and lack of sleep
CC       can precipitate attacks. {ECO:0000269|PubMed:25676728}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- MISCELLANEOUS: Both the 120 kDa linear IgA disease antigen and the 97
CC       kDa linear IgA disease antigen of COL17A1, represent major antigenic
CC       targets of autoantibodies in patients with linear IgA disease (LAD).
CC       LAD is a subepidermal blistering disorder characterized by tissue-bound
CC       and circulating IgA autoantibodies to the dermal-epidermal junction.
CC       These IgA autoantibodies preferentially react with 97 and the 120 kDa
CC       forms, but not with the full-length COL17A1, suggesting that the
CC       cleavage of the ectodomain generates novel autoantigenic epitopes.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA35605.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH04478.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M91669; AAA35605.1; ALT_INIT; mRNA.
DR   EMBL; U76604; AAB51499.1; -; Genomic_DNA.
DR   EMBL; U76565; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76566; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76567; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76568; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76569; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76570; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76571; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76572; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76573; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76574; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76575; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76576; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76577; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76578; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76579; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76580; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76581; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76582; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76583; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76584; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76585; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76586; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76587; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76588; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76589; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76590; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76591; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76592; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76593; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76594; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76595; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76596; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76597; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76598; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76599; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76600; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76601; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76602; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; U76603; AAB51499.1; JOINED; Genomic_DNA.
DR   EMBL; AL138761; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004478; AAH04478.1; ALT_SEQ; mRNA.
DR   EMBL; M63730; AAA51839.1; -; mRNA.
DR   CCDS; CCDS7554.1; -. [Q9UMD9-1]
DR   PIR; I56325; A61262.
DR   RefSeq; NP_000485.3; NM_000494.3. [Q9UMD9-1]
DR   SMR; Q9UMD9; -.
DR   BioGRID; 107704; 17.
DR   ComplexPortal; CPX-1758; Collagen type XVII trimer.
DR   IntAct; Q9UMD9; 7.
DR   STRING; 9606.ENSP00000340937; -.
DR   Allergome; 8213; Hom s BP180.
DR   GlyGen; Q9UMD9; 1 site.
DR   iPTMnet; Q9UMD9; -.
DR   PhosphoSitePlus; Q9UMD9; -.
DR   SwissPalm; Q9UMD9; -.
DR   BioMuta; COL17A1; -.
DR   DMDM; 146345399; -.
DR   EPD; Q9UMD9; -.
DR   jPOST; Q9UMD9; -.
DR   MassIVE; Q9UMD9; -.
DR   PaxDb; Q9UMD9; -.
DR   PeptideAtlas; Q9UMD9; -.
DR   PRIDE; Q9UMD9; -.
DR   ProteomicsDB; 85187; -. [Q9UMD9-1]
DR   ProteomicsDB; 85188; -. [Q9UMD9-2]
DR   Antibodypedia; 18201; 232 antibodies.
DR   DNASU; 1308; -.
DR   Ensembl; ENST00000369733; ENSP00000358748; ENSG00000065618. [Q9UMD9-2]
DR   Ensembl; ENST00000648076; ENSP00000497653; ENSG00000065618. [Q9UMD9-1]
DR   GeneID; 1308; -.
DR   KEGG; hsa:1308; -.
DR   UCSC; uc001kxr.4; human. [Q9UMD9-1]
DR   CTD; 1308; -.
DR   DisGeNET; 1308; -.
DR   GeneCards; COL17A1; -.
DR   GeneReviews; COL17A1; -.
DR   HGNC; HGNC:2194; COL17A1.
DR   HPA; ENSG00000065618; Tissue enhanced (placenta, skin, tongue).
DR   MalaCards; COL17A1; -.
DR   MIM; 113811; gene.
DR   MIM; 122400; phenotype.
DR   MIM; 226650; phenotype.
DR   neXtProt; NX_Q9UMD9; -.
DR   OpenTargets; ENSG00000065618; -.
DR   Orphanet; 293381; Epithelial recurrent erosion dystrophy.
DR   Orphanet; 79402; Junctional epidermolysis bullosa, generalized intermediate.
DR   Orphanet; 79406; Late-onset junctional epidermolysis bullosa.
DR   Orphanet; 251393; Localized junctional epidermolysis bullosa, non-Herlitz type.
DR   PharmGKB; PA26710; -.
DR   VEuPathDB; HostDB:ENSG00000065618.16; -.
DR   eggNOG; KOG3544; Eukaryota.
DR   GeneTree; ENSGT00940000161242; -.
DR   HOGENOM; CLU_004285_0_0_1; -.
DR   InParanoid; Q9UMD9; -.
DR   OMA; LQGSEYR; -.
DR   OrthoDB; 718661at2759; -.
DR   PhylomeDB; Q9UMD9; -.
DR   TreeFam; TF332289; -.
DR   PathwayCommons; Q9UMD9; -.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-446107; Type I hemidesmosome assembly.
DR   Reactome; R-HSA-8948216; Collagen chain trimerization.
DR   BioGRID-ORCS; 1308; 21 hits in 984 CRISPR screens.
DR   ChiTaRS; COL17A1; human.
DR   GeneWiki; Collagen,_type_XVII,_alpha_1; -.
DR   GenomeRNAi; 1308; -.
DR   Pharos; Q9UMD9; Tbio.
DR   PRO; PR:Q9UMD9; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q9UMD9; protein.
DR   Bgee; ENSG00000065618; Expressed in skin of abdomen and 125 other tissues.
DR   ExpressionAtlas; Q9UMD9; baseline and differential.
DR   Genevisible; Q9UMD9; HS.
DR   GO; GO:0005604; C:basement membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005911; C:cell-cell junction; TAS:ProtInc.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0031012; C:extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0030056; C:hemidesmosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IBA:GO_Central.
DR   GO; GO:0030020; F:extracellular matrix structural constituent conferring tensile strength; HDA:BHF-UCL.
DR   GO; GO:0007160; P:cell-matrix adhesion; TAS:ProtInc.
DR   GO; GO:0030199; P:collagen fibril organization; TAS:Reactome.
DR   GO; GO:0008544; P:epidermis development; TAS:ProtInc.
DR   GO; GO:0030198; P:extracellular matrix organization; IBA:GO_Central.
DR   GO; GO:0031581; P:hemidesmosome assembly; IDA:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   InterPro; IPR008160; Collagen.
DR   Pfam; PF01391; Collagen; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Basement membrane; Cell junction; Collagen;
KW   Direct protein sequencing; Disease variant; Disulfide bond;
KW   Epidermolysis bullosa; Extracellular matrix; Glycoprotein; Hydroxylation;
KW   Membrane; Phosphoprotein; Reference proteome; Repeat; Secreted;
KW   Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN           1..1497
FT                   /note="Collagen alpha-1(XVII) chain"
FT                   /id="PRO_0000059406"
FT   CHAIN           524..1497
FT                   /note="120 kDa linear IgA disease antigen"
FT                   /id="PRO_0000342555"
FT   CHAIN           531..?
FT                   /note="97 kDa linear IgA disease antigen"
FT                   /id="PRO_0000342556"
FT   TOPO_DOM        1..467
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        468..488
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        489..1497
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   REGION          1..566
FT                   /note="Nonhelical region (NC16)"
FT   REGION          145..230
FT                   /note="Necessary for interaction with DST and for the
FT                   recruitment of DST to hemidesmosome"
FT                   /evidence="ECO:0000269|PubMed:12482924"
FT   REGION          567..1482
FT                   /note="Triple-helical region"
FT   REGION          1483..1497
FT                   /note="Nonhelical region (NC1)"
FT   MOD_RES         544
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:17545155"
FT   CARBOHYD        1421
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:9748270"
FT   VAR_SEQ         922..966
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_024940"
FT   VAR_SEQ         1170..1207
FT                   /note="GSEFRGIVGPPGPPGPPGIPGNVWSSISVEDLSSYLHT -> A (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_024941"
FT   VARIANT         4
FT                   /note="T -> A (in dbSNP:rs17116471)"
FT                   /id="VAR_048781"
FT   VARIANT         210
FT                   /note="T -> M (in dbSNP:rs805708)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_017593"
FT   VARIANT         231
FT                   /note="M -> I (in dbSNP:rs1054113)"
FT                   /evidence="ECO:0000269|PubMed:11912005,
FT                   ECO:0000269|PubMed:9012408"
FT                   /id="VAR_017594"
FT   VARIANT         238
FT                   /note="M -> T"
FT                   /evidence="ECO:0000269|PubMed:9012408"
FT                   /id="VAR_017595"
FT   VARIANT         265
FT                   /note="S -> C (in GABEB)"
FT                   /evidence="ECO:0000269|PubMed:11912005"
FT                   /id="VAR_017596"
FT   VARIANT         428
FT                   /note="G -> S (in dbSNP:rs805698)"
FT                   /evidence="ECO:0000269|PubMed:1324962,
FT                   ECO:0000269|PubMed:9012408"
FT                   /id="VAR_017597"
FT   VARIANT         627
FT                   /note="G -> V (in GABEB)"
FT                   /evidence="ECO:0000269|PubMed:10652291,
FT                   ECO:0000269|PubMed:8669466"
FT                   /id="VAR_017598"
FT   VARIANT         633
FT                   /note="G -> D (in GABEB; dbSNP:rs121912773)"
FT                   /evidence="ECO:0000269|PubMed:10951237"
FT                   /id="VAR_017599"
FT   VARIANT         703
FT                   /note="M -> V (in dbSNP:rs805722)"
FT                   /evidence="ECO:0000269|PubMed:9012408"
FT                   /id="VAR_017600"
FT   VARIANT         939
FT                   /note="T -> I (in ERED; dbSNP:rs797045142)"
FT                   /evidence="ECO:0000269|PubMed:25676728"
FT                   /id="VAR_074627"
FT   VARIANT         1303
FT                   /note="R -> Q (in GABEB; dbSNP:rs121912771)"
FT                   /evidence="ECO:0000269|PubMed:9199555"
FT                   /id="VAR_017601"
FT   VARIANT         1370
FT                   /note="D -> G (in dbSNP:rs17116350)"
FT                   /evidence="ECO:0000269|PubMed:9012408"
FT                   /id="VAR_017602"
FT   CONFLICT        856
FT                   /note="Q -> P (in Ref. 5; AAA51839)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        905
FT                   /note="S -> F (in Ref. 1; AAA35605 and 2; AAB51499)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1497 AA;  150419 MW;  E01027005F3AE843 CRC64;
     MDVTKKNKRD GTEVTERIVT ETVTTRLTSL PPKGGTSNGY AKTASLGGGS RLEKQSLTHG
     SSGYINSTGS TRGHASTSSY RRAHSPASTL PNSPGSTFER KTHVTRHAYE GSSSGNSSPE
     YPRKEFASSS TRGRSQTRES EIRVRLQSAS PSTRWTELDD VKRLLKGSRS ASVSPTRNSS
     NTLPIPKKGT VETKIVTASS QSVSGTYDAT ILDANLPSHV WSSTLPAGSS MGTYHNNMTT
     QSSSLLNTNA YSAGSVFGVP NNMASCSPTL HPGLSTSSSV FGMQNNLAPS LTTLSHGTTT
     TSTAYGVKKN MPQSPAAVNT GVSTSAACTT SVQSDDLLHK DCKFLILEKD NTPAKKEMEL
     LIMTKDSGKV FTASPASIAA TSFSEDTLKK EKQAAYNADS GLKAEANGDL KTVSTKGKTT
     TADIHSYGSS GGGGSGGGGG VGGAGGGPWG PAPAWCPCGS CCSWWKWLLG LLLTWLLLLG
     LLFGLIALAE EVRKLKARVD ELERIRRSIL PYGDSMDRIE KDRLQGMAPA AGADLDKIGL
     HSDSQEELWM FVRKKLMMEQ ENGNLRGSPG PKGDMGSPGP KGDRGFPGTP GIPGPLGHPG
     PQGPKGQKGS VGDPGMEGPM GQRGREGPMG PRGEAGPPGS GEKGERGAAG EPGPHGPPGV
     PGSVGPKGSS GSPGPQGPPG PVGLQGLRGE VGLPGVKGDK GPMGPPGPKG DQGEKGPRGL
     TGEPGMRGLP GAVGEPGAKG AMGPAGPDGH QGPRGEQGLT GMPGIRGPPG PSGDPGKPGL
     TGPQGPQGLP GTPGRPGIKG EPGAPGKIVT SEGSSMLTVP GPPGPPGAMG PPGPPGAPGP
     AGPAGLPGHQ EVLNLQGPPG PPGPRGPPGP SIPGPPGPRG PPGEGLPGPP GPPGSFLSNS
     ETFLSGPPGP PGPPGPKGDQ GPPGPRGHQG EQGLPGFSTS GSSSFGLNLQ GPPGPPGPQG
     PKGDKGDPGV PGALGIPSGP SEGGSSSTMY VSGPPGPPGP PGPPGSISSS GQEIQQYISE
     YMQSDSIRSY LSGVQGPPGP PGPPGPVTTI TGETFDYSEL ASHVVSYLRT SGYGVSLFSS
     SISSEDILAV LQRDDVRQYL RQYLMGPRGP PGPPGASGDG SLLSLDYAEL SSRILSYMSS
     SGISIGLPGP PGPPGLPGTS YEELLSLLRG SEFRGIVGPP GPPGPPGIPG NVWSSISVED
     LSSYLHTAGL SFIPGPPGPP GPPGPRGPPG VSGALATYAA ENSDSFRSEL ISYLTSPDVR
     SFIVGPPGPP GPQGPPGDSR LLSTDASHSR GSSSSSHSSS VRRGSSYSSS MSTGGGGAGS
     LGAGGAFGEA AGDRGPYGTD IGPGGGYGAA AEGGMYAGNG GLLGADFAGD LDYNELAVRV
     SESMQRQGLL QGMAYTVQGP PGQPGPQGPP GISKVFSAYS NVTADLMDFF QTYGAIQGPP
     GQKGEMGTPG PKGDRGPAGP PGHPGPPGPR GHKGEKGDKG DQVYAGRRRR RSIAVKP
//
